Vimarsana
Biggest News Aggregation in the World

Medicine Section News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medicine Section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medicine Section Today - Breaking & Trending Today

An insight into German education, research and training landscape - Vimarsana News

An insight into German education, research and training landscape

Germany is known for its well-structured and comprehensive education and research landscape, offering world class state-of-the-art institutions and research centres, spread across the country. No...

From the Pages - Vimarsana News

From the Pages

In the Beginning: 1855

LIVE-HCM Study: Insights on Hypertrophic Cardiomyopathy Management - Vimarsana News

LIVE-HCM Study: Insights on Hypertrophic Cardiomyopathy Management

Until recently, patients with HCM were advised to avoid vigorous exercise. An observational trial evaluated the health impacts of activities such as running,

Source: yale.edu
Yale Expands Cardio-Rheumatology Program - Vimarsana News

Yale Expands Cardio-Rheumatology Program

Yale provides cardiovascular risk assessment and treatment for patients with autoimmune diseases, including rheumatoid arthritis, systemic lupus, scleroderma,

Source: yale.edu
Global acclaim | The Express Tribune - Vimarsana News

Global acclaim | The Express Tribune

Global acclaim December 20, 2020 Pakistani professionals have been winning laurels around the world with their outstanding contributions in various fields. The latest to make it to the top is a Pakistan-born molecular biologist who is billed to receive the prestigious 2021 Leibniz Prize. Dr Asifa Akhtar has been recognised for her groundbreaking cell-biological work on mechanisms of epigenetic gene regulation. Holding a key position of Vice President at Germany’s Max Planck Society, Dr Asifa was picked as the winner by the DFG on December 10. She will be awarded the prize, which is endowed ...